# Can we Antagonize Mivacurium With Neostigmine ?

> **NCT03019835** · NA · COMPLETED · sponsor: **Université Libre de Bruxelles** · enrollment: 80 (actual)

## Conditions studied

- Mivacurium
- Neostigmine
- Residual Paralysis

## Interventions

- **DRUG:** Neostigmine (40 mcg / kg) at different time of neuromuscular block's recovery
- **OTHER:** Spontaneous recovery

## Key facts

- **NCT ID:** NCT03019835
- **Lead sponsor:** Université Libre de Bruxelles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-04-22
- **Final completion:** 2017-04-22
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03019835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03019835, "Can we Antagonize Mivacurium With Neostigmine ?". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03019835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*